Prosecution Insights
Last updated: October 04, 2026

I Peace Inc.

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems

4 pending office actions • 3 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

I Peace Inc. has 4 pending office actions within the Transportation, E-Commerce & Mechanical Systems technology area. These matters are handled by 3 distinct examiners across 3 distinct art units. This distribution means that the 4 pending office actions are being reviewed by several different examiners, each in a different department.

JOS, BASIL T is the busiest examiner for the company, currently overseeing 2 pending office actions. Since there are 4 pending office actions in total, this examiner holds half of the company's active workload. The involvement of 3 distinct examiners and 3 distinct art units suggests that the company's filings are being evaluated by multiple officials across different technical groups within the Transportation, E-Commerce & Mechanical Systems sector.

The fact that there are 3 distinct art units for only 4 actions indicates a high degree of technical variety in the company's current patent activity. With JOS, BASIL T managing 2 of the cases, practitioners may find some opportunity for consistent messaging, but must still account for the 3 distinct art units involved. This profile shows a technically divided set of active applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
3
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (50%)
2
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (25%)
§102 only2 (50%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
50% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JOS, BASIL T 2 78.0% +6.2%
RIGA, MICHAEL ANGELO 1 57.1% +61.2%
EBBINGHAUS, BRIANA NOEL 1 61.6% +63.5%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18146897 METHOD FOR PRODUCING NERVE CELL, METHOD FOR PRODUCING MOTOR NEURON, AND METHOD FOR SCREENING NEUROLOGICAL DISEASE THERAPEUTIC DRUG EBBINGHAUS, BRIANA NOEL 100d overdue
18615184 METHOD FOR SCREENING SUBSTANCE, SYSTEM FOR SCREENING SUBSTANCE, METHOD FOR PRODUCING A CLUMP FROM STEM CELLS, AND METHOD FOR PRODUCING DIFFERENTIATED CELLS RIGA, MICHAEL ANGELO —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18146897 METHOD FOR PRODUCING NERVE CELL, METHOD FOR PRODUCING MOTOR NEURON, AND METHOD FOR SCREENING NEUROLOGICAL DISEASE THERAPEUTIC DRUG EBBINGHAUS, BRIANA NOEL 100d overdue
18615184 METHOD FOR SCREENING SUBSTANCE, SYSTEM FOR SCREENING SUBSTANCE, METHOD FOR PRODUCING A CLUMP FROM STEM CELLS, AND METHOD FOR PRODUCING DIFFERENTIATED CELLS RIGA, MICHAEL ANGELO —

Top Art Units

Art UnitApps
3656 2
1653 1
1632 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19251801 CELL PRODUCTION SYSTEM JOS, BASIL T 3656 §102 Non-Final OA — Pending Jun 27, 2025
19251802 CELL PRODUCTION SYSTEM JOS, BASIL T 3656 §102 Non-Final OA — Pending Jun 27, 2025
18615184 METHOD FOR SCREENING SUBSTANCE, SYSTEM FOR SCREENING SUBSTANCE, METHOD FOR PRODUCING A CLUMP FROM STEM CELLS, AND METHOD FOR PRODUCING DIFFERENTIATED CELLS RIGA, MICHAEL ANGELO 1653 §101§102§112 Non-Final OA — Pending Mar 25, 2024
18146897 METHOD FOR PRODUCING NERVE CELL, METHOD FOR PRODUCING MOTOR NEURON, AND METHOD FOR SCREENING NEUROLOGICAL DISEASE THERAPEUTIC DRUG EBBINGHAUS, BRIANA NOEL 1632 §103§112 Non-Final OA 100d overdue Pending Dec 27, 2022

Managing I Peace Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month